Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
14.11
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:300452 Revenue
Anhui Sunhere Pharmaceutical Excipients had revenue of 261.39M CNY in the quarter ending March 31, 2026, with 5.45% growth. This brings the company's revenue in the last twelve months to 956.32M, up 7.12% year-over-year. In the year 2025, Anhui Sunhere Pharmaceutical Excipients had annual revenue of 942.80M with 6.82% growth.
Revenue (ttm)
956.32M
Revenue Growth
+7.12%
P/S Ratio
3.43
Revenue / Employee
897.95K
Employees
1,065
Market Cap
3.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 942.80M | 60.22M | 6.82% |
| Dec 31, 2024 | 882.57M | 43.31M | 5.16% |
| Dec 31, 2023 | 839.26M | 134.73M | 19.12% |
| Jan 1, 2023 | 704.53M | 87.82M | 14.24% |
| Dec 31, 2021 | 616.71M | 85.51M | 16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Yibai Pharmaceutical | 1.72B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.11B |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Zhejiang Shengda Bio-Pharm | 830.53M |
| Jiangxi Synergy Pharmaceutical | 828.66M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 747.80M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Honz Pharmaceutical | 466.12M |